Sign in

CIK 0001600620 · Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981231763
Phone
250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Exit or restructuring costs · Executive or director change
  3. 3 Insider Initial Statement of Ownership
  4. 4 Insider Changes in Ownership
  5. SC 13D Stake Beneficial Ownership Report
  6. 8-K Event Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
  7. 4 Insider Changes in Ownership
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 8-K Event Shareholder vote results
  11. DEFA14A Proxy Proxy Materials
  12. DEFA14A Proxy Proxy Materials
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. ARS Other Annual Report to Security Holders
  19. DEFA14A Proxy Proxy Materials
  20. DEF 14A Proxy Proxy Statement

Page 6 of 31 · 615 filings